---
title: "Vivifrail 36-Week Programme Yields Reproducible SPPB and Sarcopenia Improvements in Older Adults"
id: "medrxiv-2-restoring-physical-resilience-consistent-functional-and-sarcopenia-gains-across"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-restoring-physical-resilience-consistent-functional-and-sarcopenia-gains-across"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1?rss=1"
published_at: "2026-10-16T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Vivifrail 36-Week Programme Yields Reproducible SPPB and Sarcopenia Improvements in Older Adults
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-restoring-physical-resilience-consistent-functional-and-sarcopenia-gains-across
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1?rss=1)
- **Published At:** 2026-10-16T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Service evaluation assessed a 36-week community multicomponent exercise programme (the **Vivifrail** model) in older adults across two consecutive cycles, analysing outcomes in a pooled sample of 178 participants. - Design was quasi-experimental, single-arm, repeated-measures; investigators reported baseline and post-intervention assessments and explicitly state that the design precludes causal inference. - The primary outcome was the **SPPB** (Short Physical Performance Battery) score; secondary measures included Timed Up and Go (TUG), handgrip strength, 6-metre walk time and MMSE. - Probable sarcopenia was defined according to EWGSOP2 criteria and tracked pre- and post-programme; frailty category based on SPPB and an identically computed fall-risk indicator were also reported. - Across the pooled sample, mean **SPPB** increased by 1.33 points (investigators reported Cohen’s d = 0.96; p < .001); 72.8% of participants reached a substantial minimal clinically important difference as reported by the authors. - All four secondary functional outcomes improved with statistical significance (authors reported all q < .005); effect sizes for SPPB, handgrip and 6-metre walk were consistent between cohorts. - Probable sarcopenia prevalence fell from 17.4% to 5.4% (p = .006) in the pooled sample; elevated fall risk declined from 19.7% to 11.2% (p = .002). - The Time × Cohort interaction reached significance for TUG only, indicating differential change in that measure between the two cycles; the source did not provide further mechanistic explanations for this interaction. - The authors declare no competing interests and state compliance with national regulations that exempted formal IRB approval for this non-experimental service evaluation; data available on request.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Restoring Physical Resilience: Consistent Functional and Sarcopenia Gains Across Two Vivifrail Cohorts [ View ORCID Profile](http://orcid.org/0000-0002-9236-9504)Javier Fernandez-Ortega, Javier Loza-Herbella, Juan A. Rangel-Garcia, [ View ORCID Profile](http://orcid.org/0000-0002-8089-650X)Andres B. Fernandez-Revelles doi: https://doi.org/10.64898/2026.10.14.26365508 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Javier Fernandez-Ortega 1 Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Javier%2BFernandez-Ortega%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fernandez-Ortega%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJavier%2BFernandez-Ortega%2B) * [ORCID record for Javier Fernandez-Ortega](http://orcid.org/0000-0002-9236-9504 "Open in new tab") * For correspondence: fernandezortegaj@ugr.es Javier Loza-Herbella 2 Santonna Town Council * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Javier%2BLoza-Herbella%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Loza-Herbella%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJavier%2BLoza-Herbella%2B) Juan A. Rangel-Garcia 2 Santonna Town Council * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Juan%2BA.%2BRangel-Garcia%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rangel-Garcia%20JA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJuan%2BA.%2BRangel-Garcia%2B) Andres B. Fernandez-Revelles 1 Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andres%2BB.%2BFernandez-Revelles%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fernandez-Revelles%20AB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndres%2BB.%2BFernandez-Revelles%2B) * [ORCID record for Andres B. Fernandez-Revelles](http://orcid.org/0000-0002-8089-650X "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1323730/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1323730/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1323730/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1323730/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1323730/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objectives: To evaluate change in physical function and probable sarcopenia following a 36-week community multicomponent exercise programme (Vivifrail model) across two consecutive cycles, and to assess the consistency of this change between cohorts. Study design: Quasi-experimental, single-arm, repeated-measures service evaluation. Ninety-two older adults (2025-2026 cohort; mean age 75.9 years, 88.0% women) completed baseline and post-intervention assessments; an independent 2024-2025 cohort (n = 86) was analysed jointly for replication (n = 178). Main outcome measures: Short Physical Performance Battery (SPPB) score (primary); Timed Up and Go (TUG), handgrip strength, 6-metre walk time and Mini-Mental State Examination (MMSE) (secondary); probable sarcopenia (EWGSOP2), SPPB-based frailty category, and a fall-risk indicator computed identically in both cohorts. Results: SPPB improved by a mean of 1.33 points (Cohen's d = 0.96; p The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.10.05.26364655v2 "Accelerated high-capacity 6 mA transcranial direct current stimulation for major depression")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.14.26365591v1 "Does the Disease-free Survival Benefit of Adding Belzutifan to Adjuvant Pembrolizumab Persist Beyond the Planned Treatment Period? A Reconstructed Individual Patient Data Analysis of Phase 3 Renal Cell Carcinoma Trials") Posted October 16, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/16/2026.10.14.26365508.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.14.26365508v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/16/2026.10.14.26365508.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Restoring Physical Resilience: Consistent Functional and Sarcopenia Gains Across Two Vivifrail Cohorts Javier Fernandez-Ortega, Javier Loza-Herbella, Juan A. Rangel-Garcia, Andres B. Fernandez-Revelles medRxiv 2026.10.14.26365508; doi: https://doi.org/10.64898/2026.10.14.26365508 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365508v1%26text%3DRestoring%2520Physical%2520Resilience%253A%2520Consistent%2520Functional%2520and%2520Sarcopenia%2520Gains%2520Across%2520Two%2520Vivifrail%2520Cohorts "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365508v1%26t%3DRestoring%2520Physical%2520Resilience%253A%2520Consistent%2520Functional%2520and%2520Sarcopenia%2520Gains%2520Across%2520Two%2520Vivifrail%2520Cohorts "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365508v1%26title%3DRestoring%2520Physical%2520Resilience%253A%2520Consistent%2520Functional%2520and%2520Sarcopenia%2520Gains%2520Across%2520Two%2520Vivifrail%2520Cohorts%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365508v1%26title%3DRestoring%2520Physical%2520Resilience%253A%2520Consistent%2520Functional%2520and%2520Sarcopenia%2520Gains%2520Across%2520Two%2520Vivifrail%2520Cohorts "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.14.26365508) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.10.14.26365508v1&count=horizontal&via=&text=Restoring%20Physical%20Resilience%3A%20Consistent%20Functional%20and%20Sarcopenia%20Gains%20Across%20Two%20Vivifrail%20Cohorts&counturl=www.medrxiv.org/content/10.64898/2026.10.14.26365508v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (629) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (343) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4927) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (488) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (422) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (667) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1659) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16132) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (35) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1229) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7176) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (741) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1081) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5190) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1453) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1811) * [Hematology](https://www.medrxiv.org/collection/hematology) (596) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1366) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16404) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1189) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (687) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (734) * [Neurology](https://www.medrxiv.org/collection/neurology) (7451) * [Nursing](https://www.medrxiv.org/collection/nursing) (374) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1111) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1275) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1024) * [Oncology](https://www.medrxiv.org/collection/oncology) (3694) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1077) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (400) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (461) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (488) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (142) * [Pathology](https://www.medrxiv.org/collection/pathology) (715) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1838) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (745) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (780) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6043) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9890) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2482) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1495) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1260) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (655) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (792) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (591) * [Surgery](https://www.medrxiv.org/collection/surgery) (794) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (314) * [Urology](https://www.medrxiv.org/collection/urology) (300) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations fo
## Related Clinical Research

- [Cell-free telomeric DNA and integrity indices linked to mental and somatic burden in axial spondyl](https://medichelpline.com/clinical-feed/medrxiv-0-cell-free-telomeric-dna-and-integrity-indices-in-axial-spondyloarthritis.md)
- [Sanders’ Medicare for All Gains Increasing Support Among Democrats in Congress](https://medichelpline.com/clinical-feed/stat-news-6-sanders-medicare-for-all-plan-accrues-more-liberal-and-moderate-support-in.md)
- [Reanalysis of isotope-resolved metabolomics in patient-derived lung cancer tissue: treatment- and](https://medichelpline.com/clinical-feed/medrxiv-1-treatment-and-tissue-context-specific-isotope-labeling-patterns-in-patient.md)
- [USPSTF to meet after yearlong pause to review key preventive recommendations](https://medichelpline.com/clinical-feed/stat-news-0-stat-influential-preventive-services-panel-to-meet-for-first-time-in-more-than.md)
- [Cost-effectiveness and cost-utility of integrated mental health video consultations (PROVIDE-C)](https://medichelpline.com/clinical-feed/pubmed-42462930.md) (DOI: 10.1016/j.jad.2026.122280)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.